Alerts will be sent to your verified email
Verify Email
VAPIENTER
|
Vapi Enterprise
|
Sangal Papers
|
Cella Space
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
22.05 % | 5.26 % | -4.43 % |
|
5yr Avg Net Profit Margin
|
544.65 % | 1.17 % | 15.14 % |
|
Price to Book
|
0.81 | 0.7 | 0.0 |
|
P/E
|
19.94 | 10.55 | 0.56 |
|
5yr Avg Cash Conversion Cycle
|
0.0 | 40.25 Days | -5005.03 Days |
|
5yr Average Interest Coverage Ratio
|
1966.47 | 2.23 | 5.25 |
|
5yr Avg ROCE
|
7.54 % | 9.23 % | 7.4 % |
|
5yr Avg Operating Profit Margin
|
-11.02 % | 3.22 % | 40.3 % |
|
5 yr average Debt to Equity
|
-0.57 | 0.6 | -1.99 |
|
5yr CAGR Net Profit
|
33.61 % | 6.1 % | -9.87 % |
|
5yr Average Return on Assets
|
19.76 % | 2.43 % | 5.55 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
38.79 % | 39.48 % | 58.5 % |
|
Share Pledged by Promoters
|
0.0 | 38.76 % | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
0.0 | 0.0 | 2.17 % |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
|
Vapi Enterprise
|
Sangal Papers
|
Cella Space
|
|---|